A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!

  • H H Dubben
  • Hans-Peter Beck-Bornholdt

Bibliographical data

Original languageGerman
Article number2
ISSN0360-3016
Publication statusPublished - 2001
pubmed 11579925